STOCKWATCH
·
Pharmaceuticals
Acquisitions21 Jan 2026, 02:48 pm

Torrent Pharmaceuticals Completes 46.39% Stake Acquisition in J.B. Chemicals & Pharmaceuticals

AI Summary

Torrent Pharmaceuticals Ltd. has completed the acquisition of 7,44,81,519 equity shares of J.B. Chemicals & Pharmaceuticals Limited, representing 46.39% of the equity share capital on a fully diluted basis. This acquisition was from Tau Investment Holdings Pte. Ltd. and was executed pursuant to a share purchase agreement dated 29th June 2025. Following this acquisition, Torrent Pharmaceuticals has acquired control of J.B. Chemicals & Pharmaceuticals and has been classified as a ‘promoter’ with effect from 21st January 2026. The company also holds an additional 1,317 equity shares of J.B. Chemicals & Pharmaceuticals, bringing their total holding to 46.39%.

Key Highlights

  • Torrent Pharmaceuticals acquires 46.39% stake in J.B. Chemicals & Pharmaceuticals from Tau Investment Holdings Pte. Ltd.
  • The acquisition was executed pursuant to a share purchase agreement dated 29th June 2025.
  • Torrent Pharmaceuticals has acquired control of J.B. Chemicals & Pharmaceuticals and has been classified as a ‘promoter’ with effect from 21st January 2026.
  • The total number of equity shares acquired is 7,44,82,836, representing 46.39% of the equity share capital of J.B. Chemicals & Pharmaceuticals on a fully diluted basis.
  • This acquisition strengthens Torrent Pharmaceuticals’ presence in the pharmaceuticals industry.
TORNTPHARM
Pharmaceuticals
TORRENT PHARMACEUTICALS LTD.

Price Impact